Standardized Pricing: An Antidote to Long-Standing Care and Cost Outcomes Analysis Frustrations

A new whitepaper from PurpleLab illustrates how data platforms with standardized pricing can empower life sciences companies to simultaneously improve outcomes and reduce costs.

Understanding costs and outcomes has loomed as a challenge for healthcare organizations for many years. To prove that patients are getting effective and cost-efficient treatments in the real world, life sciences leaders need to ask many questions such as:

• Are patients taking the drug as directed?
• Are patients having less or more physician visits after starting the therapy?
• Is the treatment reducing the comprehensive cost – or the overall burden of care for individual patients?